GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the VEGFR2 kinase domain in complex with motesanib

Analyse Crystal structure of the VEGFR2 kinase domain in complex with motesanib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3EFL
Type
protein
Length
549 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vascular endothelial growth factor receptor 2
EC
2.7.10.1
UniProt
P35968
Ligands
706
Pockets
4 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein28645% helix, 16% strandP35968
BVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein26344% helix, 19% strandP35968

Ligands and binding sites

  • 706 · N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13590.710.8348706
23630.700.8341706
33770.640.7830empty
4540.320.7612empty

Interfaces

1 interface between chains.

  • A–B · 494 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 3EFL · Crystal structure of the VEGFR2 kinase domain in complex with motesanib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.